Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

NCT03344211 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Castration-Resistant Prostate Carcinoma
Prostate Carcinoma Metastatic in the Bone
Stage IV Prostate Cancer

Interventions

DRUG: Enzalutamide
OTHER: Laboratory Biomarker Analysis
RADIATION: Radium Ra 223 Dichloride

Sponsor

University of Southern California

Collaborators

[object Object]